Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study

International Journal of Hyperthermia

Volumn 27, Issue 2, 2011, Pages 180-186

  Hua, Yonghong ^a   Ma, Shenglin ^a   Fu, Zhenfu ^a   Hu, Qiaoying ^a   Wang, Lei ^a   Piao, Yongfeng ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Intracavity hyperthermia; local tumour control; nasopharyngeal cancer; survival; toxicity

Indexed keywords

CISPLATIN; DIURETIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLISTER; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; DENTAL CARIES; DIURETIC THERAPY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEARING IMPAIRMENT; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MOUTH MUCOSA; NASOPHARYNGEAL NEOPLASMS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 79951600883     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.503982     Document Type: Article

References (25)

1. Au JS, Law CK, Foo W, Lau WH. In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: Prognostic homogeneity and proposed refinements. In (Pubitemid 36542900)
2. Liu XQ, Luo W, Liu MZ, Ye L, Sun Y, Xia YF. Treatment results and prognostic analysis of 1093 primary nasopharyngeal carcinoma: The experience of a single institution of Guangzhou in the beginning of the 21st century. Chin-Ger J Clin Oncol 2008;7:187-195.
3. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, et al. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience. Int J Radiat Oncol Biol Phys 2005;61:1107-1116. (Pubitemid 40340904)
4. Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, Leung SF, Cheung FY, Yeo W, Yiu HH, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-2044. (Pubitemid 34408793)
5. Overgaard J, Gonzalez-Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995;345:540-543.
6. Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, Budach V, Felix R, Schlag PM. Preoperative radio-chemotherapy in locally advanced recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000;48:381-391.
7. Van der Zee J, González Gonzáles D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomised, multicentre trial. Lancet 2000;355:1119-1125. (Pubitemid 30172932)
8. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, González González D, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996;35:731-744. (Pubitemid 26251128)
9. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655. (Pubitemid 13149996)
10. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214. (Pubitemid 11167383)
11. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
12. Zhu L, Chen ZJ, Wang W, Li RY, Wang P. Intracavitary thermotherapy combined with radiotherapy for nasopharyngeal carcinoma. Chin J Clini Oncol 2005;10:585-587. (Pubitemid 40862954)
13. Svetisky PV. Effect of microwave and ionizing radiation in patients with recurrent laryngeal carcinoma. J Laryngol Otol 1990;104:704-705.
14. Huilgol NG, Gupta D, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia 2010;26:21-25.
15. Chen ZB, Ren QR, Li CQ. Comparison of the long-term results between two radiotherapeutic protocols for nasopharyngeal carcinoma patients with involvement of the parapharyngeal space. Chin J Radiat Oncol 1999;8:69-72.
16. Teo P, Lee WY, Yu P. The prognostic significance of parapharyngeal tumor involvement in nasopharyngeal carcinoma. Radiother Oncol 1996;39:209-221. (Pubitemid 26162022)
17. Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005;62:672-679. (Pubitemid 40779753)
18. Sham JS, Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991;13:298-310.
19. Wu, JB, Chen CQ. A controlled clinical study of intracavitary microwave hyperthermia combined with lrradiation for nasopharyngeal carcinoma. J QILU Oncol 1996;3:200-203.
20. Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005;181:35-41. (Pubitemid 40174984)
21. Zhang EP, Lian PG, Cai KL, Chen YF, Cai MD, Zheng XF, Guang XX. Radiation therapy of nasopharyngeal cancer: Prognostic factors based on a 10-year followup of 1302 patients. Int J Radiat Oncol Biol Phys 1989;16:301-305.
22. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, Tung SY, Thaw M, Ho JH. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270.
23. Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP, Xu GZ. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten year experience of a single institution. Int J Radiat Oncol Biol Phys 2006;65:161-168.
24. Gao YS, Hu CS, Ying HM, Zhu GP, Kong L, He XY, Xu TT, Wang XS, Yuan J, Wu SQ, et al. Treatment results of nasopharyngeal carcinoma: A retrospective analysis of 1837 cases in a single institute. Chin J Radiat Oncol 2008;17:335-339.
25. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3684-3690.